filmov
tv
Trials for progressive MS to be launched
Показать описание
A world-first clinical trial for progressive multiple sclerosis (MS) treatments will launched in the UK later this year.
The MS Society aim to be able to evaluate new treatments more quickly by testing them together, and by combining trial phases.
There are currently no treatments that can halt the condition, which leads to progressively severe disability.
The MS Society aim to be able to evaluate new treatments more quickly by testing them together, and by combining trial phases.
There are currently no treatments that can halt the condition, which leads to progressively severe disability.
Trials for progressive MS to be launched
Live Q&A - Clinical Trials for Progressive MS
25 at 25: OCTOPUS – speeding up new treatments for progressive MS
MS Research: BTK-inhibitor #shorts
Multiple Sclerosis RESEARCH BREAKTHROUGH!
Professor Jeremy Chataway - Octopus - inside the progressive MS mega-trial
Octopus: a revolutionary multi-arm, multi-stage trial for progressive MS
Why we need to find treatments for progressive MS | MS Society's Octopus trial
Immunic COO Jason Tardio discusses key 2024 highlights, 2025 milestones
Octopus – inside the progressive MS mega-trial
Phase III trials of tolebrutinib in relapsing-remitting and progressive MS
New Treatments for Progressive MS – International Progressive MS Alliance
Post Hoc Analysis: Phase 3 EXPAND Trial in Secondary Progressive MS
New Treatment for Progressive MS
Driving progress in progressive MS with multi-arm trials
Analyzing Phase 2 CALLIPER Trial of IMU 838 for Progressive MS
The PLATYPUS clinical trial – a new type of clinical trial for progressive MS
PLATYPUS: Inside the Pioneering Adaptive Clinical Trial for Progressive MS
Progressive MS: Implications of the EXPAND Trial
How will Octopus affect the treatment of progressive MS?
MIS416: Clinical Trial for Secondary Progressive MS - Personal experience
Anti-EBV trial shows promise in Progressive MS
What we are learning from clinical trials
MIS416: Clinical Trial for Secondary Progressive MS - Participation
Комментарии